Researchers have developed a drug that hopes to win the fight against antibiotic-resistant bacteria. Observations have shown that this medicine successfully copes with 300 types of data dangerous to health and life of microorganisms.
Scientists at the University of Illinois in the US have developed a drug that could end the problem of antibiotic resistance, or so-called superbugs. We are talking about an artificial antibiotic called fabimicin, which destroys hundreds of resistant bacteria that do not respond to all other antibacterial drugs. Superbugs are responsible for up to 7 million deaths each year, and some experts say they should be taken as seriously as the threat of global warming.
New drug against malaria tested
Due to evolution, bacteria have developed resistance to common antibiotics, which is explained by the uncontrolled prescription of these drugs, as well as self-medication of patients who calmly purchase pills at any pharmacy. Today in Russia, a person can buy almost any antibiotic without any problems and start self-treatment of some cough or fever, although there is no reason for this. Under the influence of antibiotics, real bacteria develop resistance, and only then stop responding to these drugs.
Iranian scientists develop new cancer drug
Study shows that fabimycin rids tissues of resistant pneumonia and urinary tract infections in mice. Further studies in the laboratory showed that this drug is also effective against 300 other superbugs. The researchers hope their findings will pave the way to combat some of the most stubborn infections in humans. (READ MORE) 
University of Illinois
Medicine
Illinois public university system, consisting from three campuses